CREB researcher Maria Pau Ginebra selected as a finalist for the EU Prize for Women Innovators

Researcher Maria Pau Ginebra, full professor of Materials Science and director of the Biomaterials Division of the UPC’s Biomedical Engineering Research Centre (CREB), has been selected as one of the 12 finalists for the 2018 EU Prize for Women Innovators.

Mar 23, 2018

The 2018 Prize for Women Innovators is awarded by the European Union in the framework of the Horizon 2020 programme, with the aim of raising awareness of the need to innovate and encouraging more women to become entrepreneurs. Each finalist must have founded or co-founded a successful company based on innovative ideas or projects that have reached the market. As well as being a CREB researcher, Maria Pau Ginebra is the founder of Mimetis Biomaterials, a spin-off of the Biomaterials, Biomechanics and Tissue Engineering Group that focuses on the design and manufacture of new synthetic biomaterials for bone regeneration and orthopaedic applications.

The research area of Maria Pau Ginebra, director of the Department of Materials Science and Metallurgy and professor at the Barcelona East School of Engineering (EEEBE), is the design of new biomaterials for regenerative medicine and controlled release of drugs, especially in the field of bone regeneration. She has received several awards, including an award from the ICREA Academia programme of the Catalan government in the field of technology and engineering in 2014 and a Narcís Monturiol Medal for scientific and technological merit in 2012.

The results of the EU Prize will be announced on 25 and 26 June. The finalists were selected by a jury of independent experts from the academic, business, venture capital and entrepreneurship spheres. The call received submissions from 122 women from all the EU member states and the countries associated with the Horizon 2020 programme. The companies created by the candidates are based on innovative ideas in a wide range of sectors, including health, biotechnology and social innovation.

More information: